UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Complex Regional Pain Syndrome.

ABSTRACT:

Background

Complex regional pain syndrome is characterized by severe, persistent pain. Emerging evidence suggests that cannabis-based medicinal products may represent a new therapeutic option. However, to date, no clinical studies have evaluated the effects of cannabis-based medicinal products in individuals with complex regional pain syndrome. The aim of this study is to assess changes in patient-reported outcome measures and the prevalence of adverse events associated with cannabis-based medicinal products prescribed for complex regional pain syndrome.

Methods

This case series assessed changes in patient-reported outcome measures over 6 months in complex regional pain syndrome patients enrolled in the UK Medical Cannabis Registry. Adverse events were measured and graded us

SUBMITTER: Evans L 

PROVIDER: S-EPMC12405601 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature